Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

cyclopia sequence 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Tuberous Sclerosis 1 Sezary Syndrome 1 Seizures 1 Prostatic Neoplasms 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lung Neoplasms 1 Lennox Gastaut Syndrome 1 Epilepsy 1 Epilepsies, Myoclonic 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Cancers 1 Adenomatous Polyposis Coli 1

Interventions

X-Rays 1 Vorinostat 1 Sorafenib 1 Magnetic Resonance Spectroscopy 1 Erlotinib Hydrochloride 1 Curcumin 1 Cetuximab 1 AH 111585 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Advanced Cancers × Curcumin × Clear all

NCT01608139 2012-10-19

Study of Curcumin, Vorinostat, and Sorafenib

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡